6550--Blood Type IVD Reagents
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
262-NETWORK CONTRACT OFFICE 22 (36C262)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36C26226Q0977
NAICS
325413 - In-Vitro Diagnostic Substance Manufacturing
Classification Code
6550
Additional Details
Documents5
The Department of Veterans Affairs, through its 262-Network Contract Office 22, has issued a Combined Synopsis/Solicitation for the procurement of Blood Type In-Vitro Diagnostic (IVD) Reagents. This opportunity, identified by procurement number 36C26226Q0977, is currently active and seeks qualified vendors capable of supplying reagents essential for blood typing and related diagnostic procedures.
The primary objective of this procurement is to secure a reliable supply of IVD reagents that meet the rigorous standards required for clinical use within VA healthcare facilities. These reagents are critical components in laboratory testing, supporting accurate blood typing and ensuring the safety and efficacy of transfusion services provided to veterans. The scope of the contract likely encompasses the delivery of reagents that are compatible with existing laboratory equipment and protocols, though specific technical requirements and quantities are detailed in the attached solicitation documents.
This procurement falls under NAICS code 325413, which pertains to In-Vitro Diagnostic Substance Manufacturing, and is classified under Product Service Code 6550. Vendors specializing in the manufacture or distribution of diagnostic reagents for clinical laboratories are the primary audience for this solicitation. The contract is managed by the federal office of the Department of Veterans Affairs, specifically the Network Contract Office 22, which oversees procurement activities for the region.
Interested parties should note that the solicitation is being conducted as a combined synopsis/solicitation, streamlining the process by combining the pre-solicitation and solicitation phases. This approach may expedite the evaluation and award process. The notice does not specify any set-aside requirements or special considerations such as small business preferences; vendors are encouraged to review the attached documentation for further details on eligibility and submission requirements.
The point of contact for this opportunity is Marcos Diaz, who can be reached via email at [email protected] for any questions or clarifications regarding the solicitation. The notice was posted on July 14, 2026, with responses due by July 22, 2026, at 14:07. All interested contractors are advised to review the full solicitation and any attachments available through the official SAM.gov opportunity page (https://sam.gov/opp/1e3001655c764d3886fd585a32eeaf3f/view) to ensure compliance with all submission requirements and to obtain comprehensive details regarding the scope of work, evaluation criteria, and contract terms.
In summary, this procurement represents an opportunity for qualified suppliers of in-vitro diagnostic reagents to support the Department of Veterans Affairs in delivering essential laboratory services. Contractors with proven capabilities in the manufacture or distribution of blood typing reagents are encouraged to review the solicitation and consider submitting a proposal in accordance with the outlined requirements.